MedTrace Logo

Study to Investigate Sleep Apnea Patients at Altitude

NCT00514826 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-05-26

No results posted yet for this study

Summary

The purpose of the study is to investigate the effect of an altitude sojourn on patients with the obstructive sleep apnea syndrome

Conditions

  • Obstructive Sleep Apnea Syndrome

Interventions

OTHER

altitude exposure

sojourn at moderate altitude (1860m and 2590m) during 2 days/nights each

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Konrad E. Bloch, MD · Pulmonary Division, University Hospital Zurich, Switzerland

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00514826 on ClinicalTrials.gov